Chemoinformaics analysis of Pyridine, 3-(5-(p-methoxyphenyl)-2-oxazolyl)-
Molecular Weight | 252.273 | nRot | 3 |
Heavy Atom Molecular Weight | 240.177 | nRig | 17 |
Exact Molecular Weight | 252.09 | nRing | 3 |
Solubility: LogS | -3.537 | nHRing | 2 |
Solubility: LogP | 3.168 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 3 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 31 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 19 | No. of Aromatic Carbocycles | 1 |
nHetero | 4 | No. of Aromatic Hetero Cycles | 2 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 15 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 2 | No. of Arom Atom | 17 |
No. of Oxygen atom | 2 | No. of Arom Bond | 17 |
nHA | 4 | APOL | 36.8555 |
nHD | 0 | BPOL | 17.7905 |
QED | 0.716 |
Synth | 1.942 |
Natural Product Likeliness | -1.038 |
NR-PPAR-gamma | 0.03 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.978 |
Pgp-sub | 0.002 |
HIA | 0.006 |
CACO-2 | -4.453 |
MDCK | 0.0000175 |
BBB | 0.801 |
PPB | 0.936869 |
VDSS | 2.973 |
FU | 0.0588828 |
CYP1A2-inh | 0.986 |
CYP1A2-sub | 0.608 |
CYP2c19-inh | 0.945 |
CYP2c19-sub | 0.064 |
CYP2c9-inh | 0.62 |
CYP2c9-sub | 0.884 |
CYP2d6-inh | 0.9 |
CYP2d6-sub | 0.865 |
CYP3a4-inh | 0.96 |
CYP3a4-sub | 0.25 |
CL | 8.01 |
T12 | 0.27 |
hERG | 0.115 |
Ames | 0.014 |
ROA | 0.39 |
SkinSen | 0.182 |
Carcinogencity | 0.707 |
EI | 0.171 |
Respiratory | 0.251 |
NR-Aromatase | 0.974 |
Antiviral | Yes |
Prediction | 0.529843 |